{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:53:22Z","timestamp":1780354402196,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670515"],"award-info":[{"award-number":["81670515"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81500444"],"award-info":[{"award-number":["81500444"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.lfs.2017.11.027","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T20:16:21Z","timestamp":1511208981000},"page":"46-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"special_numbering":"C","title":["Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice"],"prefix":"10.1016","volume":"192","author":[{"given":"Junli","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengliang","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keshu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2017.11.027_bb0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/liv.13299","article-title":"The epidemiology of non-alcoholic fatty liver disease","volume":"37","author":"Bellentani","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.lfs.2017.11.027_bb0010","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-physiol-021115-105331","article-title":"Pathophysiology and mechanisms of nonalcoholic fatty liver disease","volume":"78","author":"Haas","year":"2016","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.lfs.2017.11.027_bb0015","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1053\/j.gastro.2014.07.056","article-title":"Pathological features of fatty liver disease","volume":"147","author":"Yeh","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2017.11.027_bb0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrd.2015.3","article-title":"Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies","volume":"15","author":"Musso","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2017.11.027_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17091575","article-title":"Molecular pathogenesis of NASH","volume":"17","author":"Caligiuri","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2017.11.027_bb0030","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2017.11.027_bb0035","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1053\/j.gastro.2016.03.004","article-title":"Perspectives on treatment for nonalcoholic steatohepatitis","volume":"150","author":"Lassailly","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2017.11.027_bb0040","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/gutjnl-2016-312431","article-title":"Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease","volume":"66","author":"Rotman","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2017.11.027_bb0045","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/MOG.0000000000000175","article-title":"Nonalcoholic fatty liver disease: new treatments","volume":"31","author":"Hardy","year":"2015","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.lfs.2017.11.027_bb0050","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/aps.2009.150","article-title":"Long-term baicalin administration ameliorates metabolic disorders and hepatic steatosis in rats given a high-fat diet","volume":"30","author":"Guo","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.lfs.2017.11.027_bb0055","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1080\/10408398.2014.952399","article-title":"The potential of flavonoids in the treatment of non-alcoholic fatty liver disease","volume":"57","author":"Van De Wier","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.lfs.2017.11.027_bb0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.phymed.2016.12.006","article-title":"Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor","volume":"25","author":"Duan","year":"2017","journal-title":"Phytomedicine"},{"key":"10.1016\/j.lfs.2017.11.027_bb0065","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejmech.2017.03.004","article-title":"Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders","volume":"131","author":"Dinda","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"15 Suppl","key":"10.1016\/j.lfs.2017.11.027_bb0070","doi-asserted-by":"crossref","first-page":"D84","DOI":"10.1046\/j.1440-1746.2000.02138.x","article-title":"Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma","author":"Shimizu","year":"2000","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2017.11.027_bb0075","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1016\/j.ijcard.2013.05.077","article-title":"Baicalin pretreatment protects against myocardial ischemia\/reperfusion injury by inhibiting mitochondrial damage-mediated apoptosis","volume":"168","author":"Wang","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.lfs.2017.11.027_bb0080","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1159\/000374037","article-title":"Baicalin attenuates high fat diet-induced obesity and liver dysfunction: dose-response and potential role of CaMKKbeta\/AMPK\/ACC pathway","volume":"35","author":"Xi","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2017.11.027_bb0085","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.mce.2017.03.027","article-title":"Baicalin against obesity and insulin resistance through activation of AKT\/AS160\/GLUT4 pathway","volume":"448","author":"Fang","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.lfs.2017.11.027_bb0090","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1159\/000459708","article-title":"Baicalin attenuates cardiac dysfunction and myocardial remodeling in a chronic pressure-overload mice model","volume":"41","author":"Zhang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2017.11.027_bb0095","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ejphar.2008.02.081","article-title":"Protective effect of baicalin against lipopolysaccharide\/d-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1","volume":"587","author":"Wan","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2017.11.027_bb0100","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2017.11.027_bb0105","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bbalip.2016.12.007","article-title":"Regulation of SREBP-2 intracellular trafficking improves impaired autophagic flux and alleviates endoplasmic reticulum stress in NAFLD","volume":"1862","author":"Deng","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Mol. Cell Biol. Lipid"},{"key":"10.1016\/j.lfs.2017.11.027_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166856","article-title":"Baicalin attenuates IL-17-mediated acetaminophen-induced liver injury in a mouse model","volume":"11","author":"Liao","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2017.11.027_bb0115","first-page":"75","article-title":"Nonalcoholic fatty liver disease: epidemiology, pathogenesis, natural history, diagnosis, and current treatment options","volume":"8","author":"Banini","year":"2016","journal-title":"Clin. Med. Insights Ther."},{"key":"10.1016\/j.lfs.2017.11.027_bb0120","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4254\/wjh.v9.i16.715","article-title":"Non-alcoholic fatty liver disease: an expanded review","volume":"9","author":"Benedict","year":"2017","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.lfs.2017.11.027_bb0125","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jhep.2010.04.033","article-title":"Down-regulation of SREBP-1c is associated with the development of burned-out NASH","volume":"53","author":"Nagaya","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2017.11.027_bb0130","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.plipres.2015.05.002","article-title":"Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research","volume":"59","author":"Willebrords","year":"2015","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.lfs.2017.11.027_bb0135","doi-asserted-by":"crossref","first-page":"21833","DOI":"10.3390\/ijms141121833","article-title":"Rodent models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"14","author":"Imajo","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2017.11.027_bb0140","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejphar.2015.11.012","article-title":"Protective role of autophagy in methionine\u2013choline deficient diet-induced advanced nonalcoholic steatohepatitis in mice","volume":"770","author":"Chen","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2017.11.027_bb0145","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2337\/db09-0016","article-title":"Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance","volume":"59","author":"Huang","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2017.11.027_bb0150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/joim.12483","article-title":"Liver innate immune cells and insulin resistance: the multiple facets of Kupffer cells","volume":"280","author":"Jager","year":"2016","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.lfs.2017.11.027_bb0155","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-pathol-121808-102132","article-title":"Nonalcoholic fatty liver disease: pathology and pathogenesis","volume":"5","author":"Tiniakos","year":"2010","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.lfs.2017.11.027_bb0160","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5009\/gnl.2012.6.2.149","article-title":"NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications","volume":"6","author":"Farrell","year":"2012","journal-title":"Gut Liver"},{"key":"10.1016\/j.lfs.2017.11.027_bb0165","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jhep.2004.08.010","article-title":"Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice","volume":"41","author":"Leclercq","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2017.11.027_bb0170","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1600-079X.2009.00676.x","article-title":"Melatonin ameliorates methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in rats","volume":"46","author":"Tahan","year":"2009","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2017.11.027_bb0175","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.metabol.2016.02.014","article-title":"Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease","volume":"65","author":"Mota","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.lfs.2017.11.027_bb0180","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s10620-014-3167-6","article-title":"Caspase 3 inactivation protects against hepatic cell death and ameliorates fibrogenesis in a diet-induced NASH model","volume":"59","author":"Thapaliya","year":"2014","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.lfs.2017.11.027_bb0185","doi-asserted-by":"crossref","first-page":"6169128","DOI":"10.1155\/2017\/6169128","article-title":"Baicalin ameliorates experimental liver cholestasis in mice by modulation of oxidative stress, inflammation, and NRF2 transcription factor","volume":"2017","author":"Shen","year":"2017","journal-title":"Oxidative Med. Cell. Longev."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320517306045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320517306045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T19:41:18Z","timestamp":1568922078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320517306045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":37,"alternative-id":["S0024320517306045"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2017.11.027","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2017.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}